发明名称 |
CONJUGATE TO STIMULATE IMMUNE RESPONSE AGAINST A TARGET CELL, METHOD TO TREAT MALIGNANT TUMORS IN MAMMALIANS |
摘要 |
medicine, immunology, oncology. SUBSTANCE: the suggested conjugate contains a monoclonal antibody C215, a monoclonal antibody C242 or their antigen-binding fragments and Staphylococcal enterotoxin A (SEA). The latter contains the mutation D227 A, reveals decreased capacity for binding to MHC antigens of type II against native SEA, keeps the capacity for binding to Vbeta T-cellular receptor. Conjugate in question is obtained due to recombinant techniques. Treatment of mammalian malignant tumors is conducted due to injection of therapeutically efficient amount of the conjugate suggested. EFFECT: higher capacity to bind to MHC antigens of type II in mammalian cells. 2 cl, 7 dwg, 3 tbl |
申请公布号 |
RU2183215(C2) |
申请公布日期 |
2002.06.10 |
申请号 |
RU19970102113 |
申请日期 |
1995.06.07 |
申请人 |
FARMATSIA EHND APDZHON AB |
发明人 |
ABRAKHMSEN LARS;B'ERK PER;DOKHLSTEN MIKAEHL';KALLAND TER'E |
分类号 |
C12N15/09;A61K38/00;A61K39/00;A61K39/395;A61K47/48;C07K14/31;C07K16/30;C07K16/32;C07K16/46;C07K19/00;C12N15/00;C12N15/01;C12P21/02;C12R1/44;(IPC1-7):C07K16/46 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|